TAS-108
http://dbpedia.org/resource/TAS-108 an entity of type: Thing
TAS-108, also known as SR-16234, is a drug discovered by Masato Tanabe and under development by SRI International and Taiho Pharmaceutical. It is a steroid hormone that has shown signs of treating and preventing breast cancer, even in patients where tamoxifen has failed.
rdf:langString
rdf:langString
TAS-108
xsd:integer
38628029
xsd:integer
1095936063
rdf:langString
BA
rdf:langString
L02
xsd:integer
33
xsd:integer
229634
xsd:integer
8050563
8050564
xsd:integer
47
rdf:langString
Citrate
xsd:integer
-14
xsd:integer
1
xsd:integer
3
xsd:integer
9874874
9874875
rdf:langString
CCNCC1=CCOC
rdf:langString
CCNCC1=CCOC.CCO
xsd:integer
1
rdf:langString
OHCPNHFLPCVWRG-MWSJHZLTSA-N
rdf:langString
VOHOCSJONOJOSD-SCIDSJFVSA-N
rdf:langString
(17β-[2-[4-[methyl]-2-methoxyphenoxy]ethyl]-7α-methylestra-1,3,5-trien-3-ol; 17β-[2-[4-[methyl]-2-methoxyphenoxy]ethyl]-7α-methylestradiol)
xsd:integer
9
42
xsd:integer
250
rdf:langString
TAS-108, also known as SR-16234, is a drug discovered by Masato Tanabe and under development by SRI International and Taiho Pharmaceutical. It is a steroid hormone that has shown signs of treating and preventing breast cancer, even in patients where tamoxifen has failed.
xsd:nonNegativeInteger
6103
xsd:string
229634-97-3
xsd:string
229634-98-4
xsd:string
42U0C8VOLO
xsd:string
9B29N23K7E
xsd:string
9874875